Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide‐induced high tumor mutational burden

Neuroendocrine neoplasm of the pancreas is a rare tumor with limited treatment options. Among such tumors, treatment for pancreatic neuroendocrine tumor (PanNET) G3 is the most difficult. Temozolomide (TMZ) is commonly used to treat PanNET. However, TMZ may cause tumor gene alkylation, which induces...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yanshuo, Ma, Yutong, Yu, Jiangyuan, Sun, Yu, Sun, Tingting, Shao, Yang, Li, Jie, Shen, Lin, Lu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743014/
https://www.ncbi.nlm.nih.gov/pubmed/33230973
http://dx.doi.org/10.1002/cac2.12114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743014/
https://www.ncbi.nlm.nih.gov/pubmed/33230973
http://dx.doi.org/10.1002/cac2.12114

Ejemplares similares